Search

everythinglearnresearchcommunity

for

Search:↓

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A woman's hair loss improved with treatment after a COVID-19 infection.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Multimedia education greatly improves women's knowledge and management of PCOS.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Insulin resistance linked to obesity may increase COVID-19 severity.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

The conference emphasized innovative solutions for global challenges, including disaster architecture, education, health, and economic impacts.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Recognizing and managing central sensitization and stress is crucial for treating chronic pain.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.